Search Results - "Domashenko, M A"

Hemorrhagic stroke and oral anticoagulants: What is to be done? by Domashenko, M. A.

“…Hemorrhagic stroke (HS) is associated with high mortality and disability rates. Due to the introduction of the current guidelines for the prevention of…”
Get full text

Full Outline of UnResponsiveness (FOUR) Scale: a Multicenter Validation Study of the Psychometric Properties of the Approved Russian Version by Piradov, M. A., Suponeva, N. A., Yatsko, K. A., Yusupova, J. G., Zimin, A. A., Legostaeva, L. A., Yazeva, E. G., Domashenko, M. A., Samorukov, V. Y., Belkin, A. A., Kondratieva, E. A., Kondratiev, S. A., Ramazanov, G. R., Kovaleva, E. A., Popugaev, K. A., Petrikov, S. S., Ryabinkina, Yu. V.

“…Assessment of the individual level of consciousness on admission of a patient with brain injury to the intensive care unit (ICU) is a priority task and a…”
Get full text

Aspirin Resistance: Clinical and Molecular Genetic Evaluation Techniques by Tanashyan, M. M., Domashenko, M. A., Raskurazhev, A. A.

“…The article discusses the issues related to the personalization of preventive measures for ischemic stroke, in particular those associated with resistance to…”
Get full text

MELDONIUM EFFICACY IN CHRONIC CEREBROVASCULAR DISEASES by M. A. DOMASHENKO, M. Yu. MAKSIMOVA

“…The evidential base of meldonium in chronic cerebral ischemia is critically reviewed in the article…”
Get full text

Personified Approaches to Reperfusion Therapy of Ischemic Stroke by Domashenko, M. A., Maksimova, M. Yu, Gafarova, M. E., Tanashyan, M. M., Antonova, K. V., Piradov, M. A.

“…Introduction: Systemic thrombolytic therapy (STLT) with recombinant tissue plasminogen activator (rtPA) is the “gold standard” of reperfusion therapy in…”
Get full text

Glasgow Coma Scale: Linguistic-Cultural Adaptation of the Russian Version by Piradov, M. A., Suponeva, N. A., Ryabinkina, Yu. V., Gnedovskaya, E. V., Ilyina, K. A., Yusupova, D. G., Zimin, A. A., Legostaeva, L. A., Yazeva, E. G., Bakulin, I. S., Zaitsev, A. B., Polekhina, N. V., Bundhun, P., Ramchandani, N. M., Samorukov, V. Y., Domashenko, M. A.

“…INTRODUCTION Determination of the degree of depression of consciousness in patients with brain damage upon admission to the intensive care unit and intensive…”
Get full text

Poststroke cognitive impairment and dementia by D. V. Sergeev, M. A. Domashenko, M. A. Piradov

“…Post-stroke cognitive impairment and dementia are one of the major causes of the disability and quality of life deterioration following cerebrovascular…”
Get full text

THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE by Kryukov, A. V., Sychev, D. A., Andreev, D. A., Ryabova, A. V., Denisenko, N. P., Loskutnikov, M. A., Vinogradov, O. I., Domashenko, M. A.

“…Aim. To study pharmacokinetics of apixaban in patients with atrial fibrillation and cardioembolic stroke in acute phase. Material and methods. 17 patients (14…”
Get full text

Extent to which transporting tanks are filled with cryogenic fluids by DOMASHENKO, A. M

Get full text

Technology of quality control of liquefied methane: A fuel for space rocket systems by DOMASHENKO, A. M, KONDRASHKOV, Yu. A

Get full text

Changes of haemostatic parameters in patients with acute cardioembolic stroke by Maksimova, M Iu, Domashenko, M A, Ionova, V G, Mikhal'chenko, V N, Syskina, E N, Okhtova, F R

“…Haemostatic parameters: platelet aggregation, hematocrit, fibrinogen, antithrombin III, fibrinolytic activity and euglobulin lysis time, plasminogen,…”
Get more information

Displacement characteristics of liquid hydrogen from stationary tanks and transporting containers by Domashenko, A. M., Blinova, I. D.

“…Heat-exchange processes between a pressurized gas, the cold wall of the container, and the phase interface in stationary and moving storage systems, and during…”
Get full text

Experience of using eculizumab in refractory myasthenia gravis by Stepanova, S B, Karpova, M I, Vasilenko, A F, Domashenko, M A

“…Myasthenia gravis (MG) is a chronic autoimmune disease mediated by autoreactive T- and B-cells and manifested by progressive pathological muscle weakness and…”
Get more information

CLINICAL EFFECTIVENESS AND ANTIOXIDANT ACTIVITY OF MILDRONATE IN ISCHEMIC STROKE by M. Yu. Maksimova, B. A. Kistenev, M. A. Domashenko, T. N. Fedorova, T. N. Sharypova

Get full text

Aspirin resistance: clinical and molecular genetic evaluation techniques by M. M. Tanashyan, M. A. Domashenko, A. A. Raskurazhev

“…The article discusses the issues related to the personalization of preventive measures for ischemic stroke, in particular those associated with resistance to…”
Get full text

Citicoline for ischemic stroke: from acute phase to rehabilitation by D. V. Sergeev, M. A. Domashenko, M. A. Piradov

“…Effective pathogenetic therapy of ischemic stroke - reperfusion intervention - is largely restricted by mandatory careful selection of patients and…”
Get full text

The course of the acute period of ischemic stroke after inravenous thrombolysis by M. A. Domashenko, M. Yu. Maksimova, M. A. Loskutnikov, A. A. Nikonov, V. V. Bryukhov

“…Intravenous (i.v.) thrombolytic therapy of acute ischemic strokeis highly effective in selected group of patients. The most commoncomplications of systemic…”
Get full text

Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 1. Acute stroke by M. A. Piradov, M. M. Tanashyan, M. A. Domashenko, D. V. Sergeev, M. Yu. Maksimova

“…The two key strategies of specific treatment of stroke are reperfusion,aimed on the improvement of brain perfusion in theischemic region due to the restoration…”
Get full text

Cerebral venous sinus thrombosis by M. V. Glebov, M. Yu. Maximova, M. A. Domashenko, V. V. Bryukhov

“…The problem of cerebral venous sinus thrombosis (CVT) stillstays in the focus of discussion due to the difficulties in diagnosticsand treatment as a result of…”
Get full text

Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 2. Chronic cerebrovascular diseases by M. A. Piradov, M. M. Tanashyan, M. A. Domashenko, M. Yu. Maksimova

“…The evidential base of major neuroprotective drugs (piracetam,cytoflavin, ethylmethylhydroxypyridine succinate, choline alphoscerate,cortexin, cerebrolysin,…”
Get full text